JPRN-UMIN000004814已完成未知
Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis Patients - Saccharated ferric oxide and FGF23
kobe university school of medicine, division of nephrology and kidney center0 个研究点目标入组 30 人开始时间: 2011年1月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •exclude a patient with menstruation, active gastrointestinal hemorrhage, tumor-bearing, hematological disorder, hepatitis and liver cirrhosis, secondary hyperparathyroidism (intact parathyroid hormon more than 500 pg/ml), parathyroidectomy.
研究者
相似试验
已完成
不适用
The effect of sucroferric oxyhydroxide starting from a small amountChronic renal failureJPRN-UMIN000034640Saitama Tsukinomori Clinic40
招募中
4 期
Effect of two different doses on hematological parameters in perimenopausal anemic women with heavy menstrual bleeding: A Randomized controlled trialCTRI/2018/05/013854AIIMS Rishikesh
已完成
不适用
Study of the efficacy of sucroferric oxyhydroxide (chewable tablet) on the control of CKD-MBD and improvement of renal anemia in hemodialysis patients with hyperphosphatemia.Hyperphosphatemia in chronic kidney disease patients on hemodialysisJPRN-UMIN000023657Kawashima Hospital, Social Medical Corporation Kawashima Hospital Group50
招募中
4 期
Effect of intravenous ferric carboxymaltose on mortality and cardiovascular morbidity, and quality of life in iron deficient patients with recent myocardial infarction2024-517206-28-00Wroclaw Medical University1,000
已完成
不适用
Efficacy and safety of sucroferric oxyhydroxide on hemodialysis patientsChronic kidney diseaseJPRN-UMIN000032867Department of Nephrology, hypertension and Endocrinology, Nihon University School of Medicine60